Source link : https://www.newshealth.biz/health-news/when-or-whether-to-give-immunotherapy-in-early-breast-cancer/
Which patients with early-stage breast cancer will benefit most from immunotherapy, and at what point is immunotherapy most useful? This question spans neoadjuvant and adjuvant settings. In the neoadjuvant setting, solid data exist demonstrating a benefit of pembrolizumab in patients with triple-negative breast cancer (TNBC), but evidence of a benefit in other subgroups is more […]
Author : News Health
Publish date : 2024-11-19 11:37:31
Copyright for syndicated content belongs to the linked Source.